Global University Venturing

The firm has launched a fund and accelerator called Boab AI that will be run by Deakin University’s former ventures director Andrew Lai.

MIT’s cancer and infectious disease therapy spinout has added $40m to a round that will support the progression of its lead asset into the clinic.

Xfund is among the backers of a $17m round for ImmuneID, which has been set up to commercialise research from Harvard University and Johns Hopkins University.

Main Sequence Ventures-backed FluroSat has joined forces with its peer Dagan and the combined business will operate from the US as Regrow.

Spacecraft manufacturer SpaceX reached a $74bn valuation, a more than sixfold increase on the $12bn it fetched when Google led a $1bn round in 2015.

Rogue has achieved a first close for its fourth fund, although it is as-yet unclear whether Oregon State University is again an investor.

University of Oxford and OSI have both returned for a $95.4m series C round that also included GV and, through the conversion of a note, Eli Lilly.

Washington University in St Louis joined a consortium of investors that provided $130m in series B financing to the commercial space station developer.

Amadeus Capital Partners has bought a stake in the University of Oxford spinout through a secondary transaction, valuing it at around $2.4bn.

The Johns Hopkins University spinout’s latest funding will go toward further developing its lead candidate, VTA-110, for muscular dystrophy treatments.

The Industrifonden-led tranche has helped the Stockholm spinout lift the round to $13.3m, which will be used to conduct a proof-of-concept run.